Clinical Trials
- Drug development
Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. These studies ensure that an investigative medicine is effective and safe, and rely entirely on patients and healthy volunteers. Learn more about clinical trials at Novartis including opportunities to get involved.
Search for Novartis clinical trials that are currently recruiting participants. A full listing of Novartis clinical trials which also includes active and completed studies can be found at ClinicalTrials.gov.
A clinical trial is a research study that is done to find out if a treatment can improve people`s health. A treatment can be a drug, medical device, medical procedure or a a change in a person`s behavior such as diet or exercise.
Why should I consider to participate in a clinical trial?
Clinical trials help to develop potential new medicines, discover if certain medicines work better than others and find new uses for already-approved medicines.
Information for Patients
Deciding to take part in a clinical trial is an important decision, and it is yours to make. Before enrolling in a clinical trial, you should learn as much as possible about the trial.
Trial summaries for patients
Novartis provides trial summaries for patients from Phase 1 through 4 interventional trials for innovative products. A trial summary for patients is a trial result written in easier to understand language than the corresponding technical result summary. The trial summary for patients is provided in English and the local languages of the trial patients.
Voluntary data sharing
Novartis is committed to sharing with qualified external researchers, access to patient-level data and clinical study reports from eligible studies.
Managed Access Programs
Managed Access makes investigational or unapproved treatments available to eligible patients with serious or life-threatening diseases.
Investigator Initiated Trials (IITs)
As part of our commitment to delivering innovative therapies to patients worldwide, Novartis believes in the need to support ethical independent clinical research conducted by qualified third-party investigators.
-
500
Clinical Trials in Progress
-
162
Projects in our global pipeline
COVID-19 Clinical Trials
Novartis is sponsoring and co-sponsoring a number of coronavirus disease (COVID-19) clinical trials and participating in multiple research collaborations
Building clinical trial diversity for long-term equity
Vas Narasimhan reflects on how to increase diversity in clinical trials
A community approach to health equity
Patrice Matchaba shares how a lifetime of experience helped shape an effort to address healthcare disparities.
Going the extra mile to keep clinical trials on track during the COVID-19 pandemic
A Novartis team couriers an experimental treatment across Europe to a patient as transit grinds to a halt